| (210) | Number of the EPO application | 18749636 |
| (220) | Filing date of the EPO application | 2018.06.27 |
| (80) | EPO patent specification publication (B) | EPB nr. 11/2023, 2023.03.15 |
| (110) | EPO patent number | 3645553 |
| (11) | Number of the document | MD 3645553 T2 |
| (21) | Number of the application | e 2020 0493 |
| (71) | Name(s) of applicant(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (72) | Name(s) of inventor(s), code of the country | SABIN Leah, US;
SCHOENHERR Christopher, US;
ECONOMIDES Aris N., US;
KYRATSOUS Christos, US;
MURPHY Andrew J., US; |
| (73) | Name(s) of owner(s), code of the country | REGENERON PHARMACEUTICALS, INC., US; |
| (54) | Title of the invention | Tropism-modified recombinant viral particles and uses thereof for the targeted introduction of genetic material into human cells |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 14/315 (2006.01.01); C12N 7/00 (2006.01.01); A61K 48/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.05.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.07.31 |
| (30) | Priority | 201762525708 P, 2017.06.27, US |
| (74) | Patent attorney | (Procedură) LAZICOV Tatiana, str. A. Pușkin nr. 33, ap. 73, MD-2012, Chișinau, Republica Moldova |
| (86) | International application | PCT/US2018/039878, 2018.06.27 |
| (87) | International publication | WO 2019/006046, 2019.01.03 |